Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for antifibrotic treatment in precirrhotic alcoholic liver disease
2011-006227-38Phase 4Terminated
- Sponsor
- Ove B. Schaffalitzky de Muckadell
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of losartan in alcoholic liver disease (ALD) and hepatic fibrosis, sponsored by Ove B. Schaffalitzky de Muckadell. Started Mar 2012; status: terminated.
02
Drugs
losartan
03
Conditions
alcoholic liver disease (ALD)hepatic fibrosis
Beyond the preview
Go deeper on 2011-006227-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006227-38.